Presentation

Academic

  • "Toxicities of antituberculosis agents:  what you need to know," presented at the 17th Pennsylvania Society of Health-System Pharmacists Midyear Conference, Pittsburgh, PA, March 21, 1996. (03/1996)
  • “Residency Pearls:  Longitudinal incorporation of the hospital pharmacy administration rotation,” presented at the 33rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1998. (12/1998)
  • “Residency Learning Systems: Update and experiences from three residency programs,” presented at the 33rd Pennsylvania Society of Health-System Pharmacists Annual Assembly Meeting, October 2001. (10/2001)
  •  “Implementation of a ventilator-associated pneumonia protocol,” presented at the 35th Pennsylvania Society of Health-System Pharmacists Annual Assembly Meeting, Seven Springs, PA, October 2003. (10/2003)
  • “Update on treatment guidelines for hospital-acquired, ventilator-associated, and health-care associated pneumonia,” presented at the 37th Pennsylvania Society of Health-System Pharmacists Annual Assembly Meeting, Seven Springs, PA, October 2005. (10/2005)
  • “Clinical Pearls:  Be Bold with the Old!” presented at the 41st American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA, December 2006. (12/2006)
  • “Is Vancomycin Obsolete for MRSA Pneumonia? Pro vs. Con Debate” presented at the Western Chapter Pennsylvania Society of Health-System Pharmacists Meeting, Pittsburgh, PA, March 2007. (03/2007)
  • “Is there a Magic Bullet for Resistant Gram-Positive Infections?”  presented at the Pennsylvania Pharmacists Association Annual Meeting, Allentown, PA, September 2007. (09/2007)
  • “Hospital Acquired Infections and Antibiotic Safety” presented at the UPMC Family Medicine Refresher Course, Pittsburgh, PA, June 2011. (06/2011)
  • “Antimicrobial Stewardship:  The Three “P” Approach” presented at the Quality Insights of Pennsylvania Clostridium difficile Conference, Pittsburgh, PA, September 2013. (09/2013)
  • “Emerging drug-resistant organisms: focus on vancomycin-resistant enterococcus,” presented to the Allegheny Critical Care Nurses Conference, Pittsburgh, PA, October 1997. (10/1997)

Poster

  • Geier M, Silvonek L, Chan-Tompkins NH.  Has the “tiger” been released from the cage? A year in review of tigecycline prescribing trends.  Student poster presentation #5-024 at the 44th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2009. (12/2009)
  • Niccolai J, Pontzer D, Bernard S, Chan-Tompkins NH.  Surgical prophylaxis medication use evaluation: assessment of intra-operative antibiotic re-dosing & pre-operative antibiotic use.  Student poster presentation #4-252 at the 46th American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, December 2011. (12/2011)
  • Vuylsteke VA, Chan-Tompkins NH, Bhat S, Medich D.  Ertapenem vs. cefotetan/metronidazole in colorectal surgery patients.  Encore poster presentation #141E at the 2011 American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA, October 2011. (10/2011)
  • Vuylsteke VA, Chan-Tompkins NH, Bhat S, Medich D.  Ertapenem vs. cefotetan/metronidazole in colorectal surgery patients.  Poster presentation #5-079 at the 45th American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA, December 2010. (12/2010)
  • Kelly C, Chan-Tompkins NH, Gallagher S.  Skip a step with CPOE: Impact on Antibiotic Ordering.  Resident poster presentation #RP350 at the 42nd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2007. (12/2007)
  • McGraw MA, Chan-Tompkins NH, Herbert C, Sahud A.  Combination vs. monotherapy for the treatment of nosocomial Clostridium difficile infection.  Poster presentation #417 at the 47th Annual Infectious Diseases Society of America Meeting, Philadelphia, PA, October 2009. (10/2009)
  • Ferrara J, Chan-Tompkins NH, Bhanot N, Herbert C, Sahud A.  Efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus (MRSA) ventilator-associated (VAP) with vancomycin MICs < 0.5 vs. vancomycin MICs > 1.  Poster presentation #384 at the 47th Annual Infectious Diseases Society of America Meeting, Philadelphia, PA, October 2009. (10/2009)
  • Ferrara J, Chan-Tompkins NH, Bhanot N, Bhat S.  Successful sterilization of Pseudomonas aeruginosa ventriculopertioneal shunt infection with intrathecal colistin.  Resident poster presentation #RP5 at the 43rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL. December 2008. (12/2008)
  • Timlin C, Chan-Tompkins NH, Gallagher S.  Assessment of medications delivered via the computerized pneumatic tube system.  Resident poster presentation #RP351 at the 42nd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2007. (12/2007)
  • Groth MH, Chan-Tompkins NH, Hegde GG, Shang J, Venkat A.An analysis of factors associated with delays in initiation of antimicrobials in the emergency department (ED) and the impact of an educational intervention to improve such administration. Poster presentation at the American College of Emergency Physicians Scientific Assembly Research Forum, Denver, CO, October 9, 2012. (10/2012)
  • Mascara GP, Simpson RW, McGill R, Chan-Tompkins NH.  Pharmacokinetics of vancomycin in patients undergoing continuous venovenous hemodialysis.  Poster presentation #A-619 at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 2012. (09/2012)
  • Desai A, Ramos-Garcia R, Chan-Tompkins NH.  Methicillin-Susceptible Staphylococcus aureus:  Are all cephalosporins equal?  Resident poster presentation #47951 at ID Week, Philadelphia, PA, October 2014. (10/2014)
  • Niccolai J, Chan-Tompkins NH.  Evaluation of piperacillin/tazobactam utilization.  Resident poster presentation #RP6-162 at the 47th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. (12/2012)
  • Campbell N, Chapman B, Chan-Tompkins NH. Assessment of micafungin use at a teaching institution. Resident poster presentation #RP6-164 at the 47th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. (12/2012)
  • McGonigle S, Desai A, Chan-Tompkins NH.  Colistimethate medication use evaluation:  focus on dosing.  Resident poster presentation #346772 at the 46th American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. (12/2013)
  • Probst JL, Schontz MJ, Chan-Tompkins NH.  Medication exposure prior to Clostridium difficile infection in a tertiary care facility.  Student poster presentation # 2-402 at the 46th ASHP Midyear Clinical Meeting, Orlando, FL, December 2013. (12/2013)
  • Weaver TD, Cockroft MN, Chan-Tompkins NH. Surgical prophylaxis medication use evaluation: an assessment of antibiotic appropriateness. Student poster presentation # 2-430 at the 46th ASHP Midyear Clinical Meeting, Orlando, FL, December 2013. (12/2013)
  • McGonigle SM, Kuroski JE, Perriello J, Donnelly S, Chan-Tompkins NH.  Medication use evaluation: adherence to weight-based cefazolin surgical prophylaxis guidelines.  Resident poster presentation #7-247 at the 49th ASHP Midyear Clinical Meeting, Anaheim, CA, December 2014. (12/2014)
  • Konopka C, Chan L, Chan-Tompkins NH, Moffa M, Burkitt M, Walsh TL.  Evaluation of management of uncomplicated acute bacterial skin and skin structure infections prior to the implementation of an antimicrobial stewardship program initiative.  Resident poster presentation #1-277 at the 50th ASHP Midyear Clinical Meeting, New Orleans, LA, December 2015 (12/2015)
  • Chan-Tompkins NH, Trienski TL, Bremmer DN, Walsh TL.  Challenges in Antimicrobial Stewardship: Oritavancin for Acute Bacterial Skin and Skin Structure Infections (ABSSSIs).  Poster presentation Friday-514 at ASM Microbe 2016, Boston, MA, June 2016. (06/2016)
  • Chan L, Guarascio A, Chan-Tompkins NH, Como J.  Retrospective Analysis of Adverse Events Between Nafcillin vs. Cefazolin for Methicillin Susceptible Staphylococcus aureus Infections.  Poster presentation Friday-407 at ASM Microbe 2016, Boston, MA, June 2016. (06/2016)
  • Murillo MA, Trienski TL, Bremmer DN, Chan-Tompkins NH, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Watson C, Walsh TL.  Evaluation of the Impact of an Antimicrobial Stewardship Program Initiative in Patients with Uncomplicated Acute Bacterial Skin and Skin Structure Infections.  Poster presentation at ID Week 2016, New Orleans, LA.  Available at URL:  https://idsa.confex.com/idsa/2016/webprogram/Paper58466.html, October 2016. (10/2016)
  • Buchanan C, Sutton R, Collier C, Magrini CP, Chan-Tompkins NH, Hsiao CB.  Transitions of Care: Assessment of Antiretroviral Medication Errors in an Academic Medical Center.  Resident poster presentation Wednesday 8-128 at 51st ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2016. (12/2016)
  • Fullmer A, Chan-Tompkins NH, Piontkowsky DM.  Comparison of nephrotoxicity in patients receiving tenofovir containing highly active antiretroviral therapy (HAART) versus tenofovir-naïve HAART.  Poster presentation #P86E at the 42nd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2007. (12/2007)
  • Chan-Tompkins NH, Heintz J, Doran B, Piontkowsky DM.  Creatinine elevation trends in patients prescribed tenofovir or emtricitabine/tenofovir.  Poster presentation #P458D at the 41st American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA, December 2006. (12/2006)
  • Wochinger KM, Chan-Tompkins NH, Piontkowsky DM.  Cidofovir-induced renal failure for treatment of AIDS-associated progressive multifocal leukoencephalopathy (PML).  Resident poster presentation at the 41st American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA, December 2006. (12/2006)
  • Santibanez S, Riley DK, Slifkin M, Chan-Tompkins NH, Babinchak TJ, Rotheram EB.  Emergence of vancomycin-resistant enterococci at a large teaching hospital.  Poster presentation at the Infectious Diseases Society of America Conference, New Orleans, LA, September 1996. (09/1996)
  • Chan NH, Graziani AL.  Assessment of routine screening for Mycobacterium tuberculosis infection prior to aerosolized pentamidine therapy.  Poster presentation at the 49th American Society of Hospital Pharmacists Annual Meeting, Washington, D.C., June 4, 1992. (06/1992)
  • Chan NH, Morgan AS, Graziani AL, MacGregor RR.  Polypharmacy and adverse drug reactions in HIV-infected patients as a function of absolute CD4 lymphocyte count.  Poster presentation at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 13, 1992. (10/1992)
  • Chan NH, MacGregor R, Chua BK.  Effect of the 1993 AIDS case definition on an HIV-positive clinic population.  Poster presentation at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, October 20, 1993. (10/1993)
  • MacGregor R, Chan NH, MacGregor L, Dunbar D, Graziani A.  Tuberculin testing in an inner city methadone clinic.  Poster presentation at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, October 19, 1993.   (10/1993)
  • Chan-Tompkins NH, Beyene Y, Brennan PJ.  Pharmacokinetics study following a single dose of oral ciprofloxacin in patients with short bowel syndrome.  Poster presentation at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 5, 1994. (10/1994)
  • Chan-Tompkins NH, Riley DK.  Anti-infective utilization prior to isolation of vancomycin-resistant enterococcus.  Poster presentation at the 16th Pennsylvania Society of Hospital Pharmacists Midyear Conference, Valley Forge, PA, March 16 and 17, 1995. (03/1995)
  • Tompkins TT, Mosti EL, Chan-Tompkins NH.  Reducing a paper workflow system to a computer application in a drug information center.  Poster presentation at the 16th Pennsylvania Society of Hospital Pharmacists Midyear Conference, Valley Forge, PA, March 16 and 17, 1995. (03/1995)
  • Harnicar SJ, Chan-Tompkins NH.  Prescribing trends of daptomycin for the treatment of gram-positive infections.  Student poster presentation at the 40th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2005. (12/2005)
  • Walker JH, Chan-Tompkins NH, Babinchak TJ.  Pharmacoeconomic cost-identification analysis of medication costs in HIV-infected outpatients.  Poster presentation at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 19, 1995. (09/1995)
  • Aboulhosn SM, Chan-Tompkins NH.  Evaluation of surgical prophylaxis in patients undergoing hepatobiliary procedures.  Student poster presentation at the 30th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1995. (12/1995)
  • Mosti EL, Tompkins TT, Chan-Tompkins NH.  Improving efficiencies of a drug information center through computerization.  Poster presentation at the 52nd American Society of Health-Systems Pharmacists Annual Meeting, June 7, 1995. (06/1995)
  • Brennan SB, Chan-Tompkins NH.  Cost-savings approach to vancomycin dosing and monitoring.  Student poster presentation at the 31st American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 1996. (12/1996)
  • Chan-Tompkins NH, Nackley D, Herbert C, Peterson C, Jeffcoat D.  Multidisciplinary treatment approach to postexposure prophylaxis. Poster presentation at the 22nd Pennsylvania Society of Health-System Pharmacists Midyear Clinical Meeting, Harrisburg, PA, March 2001. (03/2001)
  • Babinchak TJ, Chan-Tompkins NH.  Clinical outcome of Candida blood stream infection based upon antifungal susceptibility testing. Poster presentation at the 35th Annual Infectious Diseases Society of America Meeting, San Francisco, CA, September 14, 1997. (09/1997)
  • Chan-Tompkins NH, Herbert C, Shaikh Z.  Is cefepime associated with a higher incidence of nosocomial Clostridium difficile when compared to other antibiotics? Poster presentation #101169 at the 40th Annual Infectious Diseases Society of America Meeting, Chicago, IL, October 2002.  (10/2002)
  • Fedutes BA, Chan-Tompkins NH, Valeriano JP.  Susac’s syndrome: case report of IVIG use.  Poster presentation at the 23rd Pennsylvania Society of Health-System Pharmacists Midyear Conference, March 2002 and Resident poster presentation at the 36th American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 2001. (12/2001)
  • Fedutes BA, Chan-Tompkins NH, Valeriano JP.  Susac’s syndrome: case report of IVIG use.  Poster presentation at the 23rd Pennsylvania Society of Health-System Pharmacists Midyear Conference, March 2002 and Resident poster presentation at the 36th American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 2001. (12/2001)
  • Chan-Tompkins NH.  Implementation of an antimicrobial management team: are costs and resistance impacted?  Poster presentation at the 39th American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2004. (12/2004)
  • Baglio M, Chan-Tompkins NH, Katz JT.  Treatment of AIDS associated progressive multifocal leukoencephalopathy (PML) with cidofovir and highly active antiretroviral therapy (HAART). Resident poster presentation at the 34th American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 1999. (12/1999)
  • Larimer LL, Chan-Tompkins NH, Babinchak TJ.  The impact of pharmacy intervention on influenza immunization rates in the elderly.  Abstract at the Eastern States Residency Conference, Baltimore, MD, April 1998 and poster presentation at the 33rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1998. (12/1998)
  • Vass G, Chan-Tompkins NH.  Optimizing patient outcomes through antibiotic order clarification.  Resident poster presentation at the 33rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1998. (12/1998)
  • Erickson L, Chan-Tompkins NH.  Impact of pharmacy inservices of aminoglycoside and vancomycin monitoring.  Resident poster presentation at the 33rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1998. (12/1998)
  • Baglio M, Chan-Tompkins NH, Byers KE.  Babesiosis in western Pennsylvania.  Student poster presentation at the 33rd American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 1998. (12/1998)

Research

  • Witucki C, Bhanot N, Chan-Tompkins NH.  Cefazolin vs. vancomycin vs. cefazolin/vancomycin prophylaxis for total joint arthroplasty.  Poster presentation (third place) at Allegheny General Hospital Department of Medicine Research Day, Pittsburgh, PA, May 2016. (05/2016)
  • “Increased influenza and pneumococcal immunization rates on an inpatient medicine team,” presented at the 34th American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2000. (12/2000)
  • “Antimicrobial susceptibility patterns before and after initiation of a ventilator associated pneumonia protocol,” presented at the 68th Chest 2002 Annual Meeting (#551338), San Diego, CA, November 2002. (11/2002)
  • "Assessment of routine screening for Mycobacterium tuberculosis infection prior to aerosolized pentamidine therapy," presented at the Eastern States Residency Conference, Baltimore, MD, April 1991. (04/1991)
  • "Assessment of medication usage in HIV-infected patients," presented at the Eastern States Residency Conference, Baltimore, MD, April 1992. (04/1992)
  • Morton MC, Chan-Tompkins NH.  Antiinfective prescribing patterns in the emergency department.  Abstract at the Eastern States Residency Conference, Baltimore, MD, April 1996. (04/1996)
  • Chan-Tompkins NH.  Assessment of antibiotic administration timing in surgical prophylaxis. Poster presentation at the 22nd Pennsylvania Society of Health-System Pharmacists Midyear Clinical Meeting, Harrisburg, PA, March 2001. (03/2001)
  • Cole MC, Chan-Tompkins NH.  Pharmacokinetic monitoring: areas for quality improvement.  Resident poster presentation at the 38th American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 2003.  Poster presentation at the 25th Pennsylvania Society of Health-System pharmacists Meeting, Pittsburgh, PA, March 2004. (03/2004)
  • Chapman B, Chan-Tompkins NH, Mancini S, Sahud A. Vancomycin colonic lavage and metronidazole combination therapy in patients undergoing diverting loop ileostomy for severe or refractory Clostridium difficile infection at a large teaching hospital.  Resident poster presentation at the Eastern States Residency Conference, Hershey, PA, May 2013.   (05/2013)
  • Desai A, Chan-Tompkins NH.  Rates of primary blood stream infections before and after implementation of chlorhexidine 2% baths in the medical intensive care unit. Resident poster presentation #55 at the Eastern States Residency Conference, Hershey, PA, May 2014. (05/2014)